TUCSON, Ariz.--(BUSINESS WIRE)--SynCardia Systems, LLC (“SynCardia” or the “Company”), maker of the SynCardia temporary Total Artificial Heart (TAH-t), today successfully completed its previously ...
TUCSON, Ariz., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total ...
TUCSON, Ariz., April 22, 2026 (GLOBE NEWSWIRE)-- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC, ("SynCardia") maker of the ...
TUCSON, Ariz.--(BUSINESS WIRE)--On March 2, Dr. Marvin Slepian, world-renowned interventional cardiologist and co-founder and chairman of SynCardia Systems, Inc., manufacturer of the SynCardia ...
SynCardia Systems yesterday withdrew its plans for an initial public offering that would have provided $27.5 million at the midpoint. Tucson-based SynCardia’s TAH-t device is currently FDA approved in ...
PALO ALTO, Calif. and TUCSON, Ariz. and ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard Medical”), the parent company of SynCardia Systems, LLC (“SynCardia”), a global leader ...
PHILADELPHIA and TUCSON – September 20, 2016 – Versa Capital Management, LLC (“Versa”) announced today that certain of its affiliates have completed, through a newly formed company SynCardia Systems, ...
TUCSON, Ariz., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total ...
TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC (“SynCardia”), maker of the ...
TUCSON, Ariz., June 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical” or the "Company”), parent company of SynCardia Systems, LLC ("SynCardia”), maker of the ...
SynCardia Systems filed for an initial public offering of 2.5 million shares, to raise up to $30 million. The medical technology company, which makes temporary artificial hearts, expects the IPO to ...